-
1 week ago | 
consultantlive.com | Steven Levine |Dominic Sisti |Jason Schwartz
In this episode of Medical Ethics Unpacked, hosts Dominic Sisti and Steve Levine welcome Jason Schwartz, PhD, associate professor at the Yale School of Public Health, for a discussion on vaccine ethics, public health infrastructure, and the challenges of maintaining trust in immunization programs. Together, they explore how the COVID-19 pandemic reshaped public attitudes toward vaccines, while also underscoring long-standing tensions between individual autonomy and collective responsibility.
-
Mar 14, 2025 | 
contagionlive.com | John Parkinson |Carl Schmid |Steven Levine
This is the second in a series on the state of HIV today. In late February, The US Business Action to End HIV, the largest coalition of employers dedicated to ending the HIV epidemic in the United States, sent a letter to Congress urging them to prioritize sustained federal funding for HIV prevention and treatment and underscoring the business sector’s commitment to advancing public health and ensuring progress in the fight against HIV.
-
Dec 9, 2024 | 
psychiatrictimes.com | Steven Levine |Heidi Anne Duerr
CommentaryArticleDecember 9, 2024Author(s):,In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.
-
Nov 22, 2024 | 
hcplive.com | Steven Levine |Dominic Sisti
Welcome to Medical Ethics Unpacked!In this episode of Medical Ethics Unpacked, hosts Dominic Sisti, PhD, and Steve Levine, MD, continue their deep dive into the controversial topic of medical aid in dying (MAID) and euthanasia for individuals with severe psychiatric conditions. Part 2 of a 2-part series, this episode shifts from foundational concepts to the intricate ethical considerations surrounding these practices, touching on autonomy, capacity, treatment equity, and societal implications.
-
Nov 14, 2024 | 
icrowdnewswire.com | Steven Levine
$197.5M ATM Surcharge Fees Class Action SettlementWhat’s the $197.5M ATM Surcharge Fees Class Action Settlement About? A total $264.24 million class action lawsuit has been settled, including a new $197.5 million settlement with Visa and MasterCard over ATM surcharges and fees that allegedly violated federal consumer protection laws.
-
Oct 23, 2024 | 
managedhealthcareexecutive.com | Steven Levine |Patricia Ares-Romero |Carrie Jardine |Samuel Norberg |Maritn Rosenzweig
Steven Levine, MD: Before we conclude, I’d like to get some final thoughts from each of you, if you have any. Let’s start with you, Dr Nordberg. Samuel Nordberg, PhD: From my perspective, treatment-resistant depression and other complex mental health challenges are systems challenges as much as they are clinical challenges. We haven’t moved the needle in treatment effectiveness in about 50 years, and in no small respect that may be because we haven’t changed our systems that provide care.
-
Oct 23, 2024 | 
managedhealthcareexecutive.com | Steven Levine |Patricia Ares-Romero |Carrie Jardine |Samuel Norberg |Maritn Rosenzweig
Steven Levine, MD: How might a payer flag a patient who’s receiving a medication like intranasal esketamine [Spravato] that requires high touch to support access and reduce delay to therapy? What are some strategies that can be employed there? Martin Rosenzweig, MD: One thing that we have a lot of is data. We also have data that fits across episode and provider, or place of service. We have mechanisms by which we can track a member course.
-
Oct 15, 2024 | 
managedhealthcareexecutive.com | Steven Levine |Patricia Ares-Romero |Carrie Jardine |Samuel Norberg |Maritn Rosenzweig
Steven Levine, MD: Let’s go back to Dr Rosenzweig for another payer-focused question. Thinking about drugs or services like intranasal esketamine [Spravato], or perhaps other nonoral alternative therapies, and in the case where there might be a combination of a drug and some service delivery component, how do you ensure the policymaking for a drug and its evaluation and management and the service component attached are integrated?
-
Oct 15, 2024 | 
managedhealthcareexecutive.com | Steven Levine |Patricia Ares-Romero |Carrie Jardine |Samuel Norberg |Maritn Rosenzweig
Steven Levine, MD: Dr Rosenzweig, you mentioned this earlier. Sometimes, and often with intranasal esketamine [Spravato], some payers may require prior authorizations prior to approving administration of that therapy. Carrie, can you talk a bit about how payers’ differing prior authorization requirements can impact patient access? Carrie Jardine: Absolutely.
-
Sep 27, 2024 | 
managedhealthcareexecutive.com | Steven Levine |Patricia Ares-Romero |Carrie Jardine |Samuel Norberg |Maritn Rosenzweig
I’m Dr Steve Levine, cofounder and non-executive chairman of the board of Heading Health in Austin, Texas, and senior vice president of patient access and medical affairs for COMPASS Pathways. Joining me in this discussion are my colleagues Dr Patricia Ares-Romero, vice president and chief medical officer of My Psychiatrist in Miami, Florida;.
